top glp-1 drugs for type 2 diabetes 2025 ISPOR 2025: Exploring reasons discontinuation GLP-1 RA prescription trends: January
Description
Int J Obes (Lond) (2016) 40(11):171522
Is your business being affected by GLP-1 medications
doi: 10.1016/j.micpath.2020.104645 [DOI] [PubMed] [Google Scholar] 154
The FDA has acknowledged the reports but has not issued an official warning about Ozempic despite the growing number of patients complaining of gastroparesis and eye conditions
